HERON THERAPEUTICS, INC. /DE/ Other Nonoperating Income (Expense)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Other Nonoperating Income (Expense) of -$3.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for the quarter ending 2026-06-30 was -$3.44M.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for the quarter ending 2026-03-31 was -$3.35M.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for the quarter ending 2025-12-31 was $4.67M, a 136.56% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for the quarter ending 2025-09-30 was -$2.06M.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for fiscal 2025 was $1.34M, a 211.40% increase from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for fiscal 2024 was $430.00K, a 23.21% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for fiscal 2023 was $560.00K.
- HERON THERAPEUTICS, INC. /DE/ other nonoperating income (expense) for fiscal 2022 was -$6.53M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.44M 10-Q · filed 2026-08-10 | -$6.79M 10-Q · filed 2026-08-10 | -$2.13M derived: sum of 3 quarters · filed 2026-08-10 | -$4.19M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | -$3.35M 10-Q · filed 2026-05-11 | $1.32M derived: sum of 2 quarters · filed 2026-05-11 | -$744.00K derived: sum of 3 quarters · filed 2026-05-11 | -$1.49M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.60M derived: sum of 2 quarters · filed 2026-02-26 | $1.86M derived: sum of 3 quarters · filed 2026-08-10 | $1.34M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$2.06M 10-Q · filed 2025-11-04 | -$2.81M derived: sum of 2 quarters · filed 2026-08-10 | -$3.33M 10-Q · filed 2025-11-04 | -$1.35M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | -$744.00K 10-Q · filed 2026-08-10 | -$1.26M 10-Q · filed 2026-08-10 | $709.00K derived: sum of 3 quarters · filed 2026-08-10 | $319.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | -$519.00K 10-Q · filed 2026-05-11 | $1.45M derived: sum of 2 quarters · filed 2026-05-11 | $1.06M derived: sum of 3 quarters · filed 2026-05-11 | -$1.73M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.58M derived: sum of 2 quarters · filed 2026-02-26 | -$1.21M derived: sum of 3 quarters · filed 2026-02-26 | $430.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$390.00K 10-Q · filed 2025-11-04 | -$3.18M derived: sum of 2 quarters · filed 2025-11-04 | -$1.54M 10-Q · filed 2025-11-04 | -$1.54M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$2.79M 10-Q · filed 2025-08-08 | -$1.15M 10-Q · filed 2025-08-08 | -$1.15M derived: sum of 3 quarters · filed 2026-02-26 | -$1.23M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $1.64M 10-Q · filed 2025-05-06 | $1.64M derived: sum of 2 quarters · filed 2026-02-26 | $1.56M derived: sum of 3 quarters · filed 2026-02-26 | $1.90M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$79.00K derived: sum of 2 quarters · filed 2026-02-26 | $265.00K derived: sum of 3 quarters · filed 2026-02-26 | $560.00K 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$79.00K 10-Q · filed 2024-11-12 | $265.00K derived: sum of 2 quarters · filed 2024-11-12 | $560.00K 10-Q · filed 2024-11-12 | $1.88M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $344.00K 10-Q · filed 2024-08-06 | $639.00K 10-Q · filed 2024-08-06 | $1.96M derived: sum of 3 quarters · filed 2025-02-27 | $1.94M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $295.00K 10-Q · filed 2024-05-07 | $1.62M derived: sum of 2 quarters · filed 2025-02-27 | $1.59M derived: sum of 3 quarters · filed 2025-02-27 | -$5.27M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.30M derived: sum of 2 quarters · filed 2025-02-27 | -$5.57M derived: sum of 3 quarters · filed 2025-02-27 | -$6.53M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$26.00K 10-Q · filed 2023-11-14 | -$6.89M derived: sum of 2 quarters · filed 2023-11-14 | -$7.85M 10-Q · filed 2023-11-14 | -$6.98M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$6.86M 10-Q · filed 2023-08-14 | -$7.83M 10-Q · filed 2023-08-14 | -$6.96M derived: sum of 3 quarters · filed 2023-08-14 | -$7.66M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$965.00K 10-Q · filed 2023-05-11 | -$97.00K derived: sum of 2 quarters · filed 2023-05-11 | -$797.00K derived: sum of 3 quarters · filed 2023-05-11 | -$1.34M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $868.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $168.00K derived: sum of 2 quarters · filed 2023-03-29 | -$378.00K derived: sum of 3 quarters · filed 2023-03-29 | -$878.00K 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$700.00K 10-Q · filed 2022-11-08 | -$1.25M derived: sum of 2 quarters · filed 2022-11-08 | -$1.75M 10-Q · filed 2022-11-08 | -$4.46M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$546.00K 10-Q · filed 2022-08-09 | -$1.05M 10-Q · filed 2022-08-09 | -$3.76M derived: sum of 3 quarters · filed 2022-08-09 | -$3.61M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | -$500.00K 10-Q · filed 2022-05-09 | -$3.22M derived: sum of 2 quarters · filed 2022-05-09 | -$3.06M derived: sum of 3 quarters · filed 2022-05-09 | -$2.50M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.56M derived: sum of 2 quarters · filed 2022-02-28 | -$2.00M derived: sum of 3 quarters · filed 2022-02-28 | -$847.00K 10-K · filed 2022-02-28 | ||
| 2020-09-30 | $156.00K 10-Q · filed 2021-11-03 | $715.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.87M 10-Q · filed 2021-11-03 | -$2.48M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $559.00K 10-Q · filed 2021-08-09 | $1.71M 10-Q · filed 2021-08-09 | -$2.63M derived: sum of 3 quarters · filed 2022-02-28 | -$1.37M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $1.16M 10-Q · filed 2021-05-10 | -$3.19M derived: sum of 2 quarters · filed 2022-02-28 | -$1.93M derived: sum of 3 quarters · filed 2022-02-28 | -$375.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | -$4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.09M derived: sum of 2 quarters · filed 2022-02-28 | -$1.53M derived: sum of 3 quarters · filed 2022-02-28 | $158.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $1.26M 10-Q · filed 2020-11-05 | $2.81M derived: sum of 2 quarters · filed 2020-11-05 | $4.50M 10-Q · filed 2020-11-05 | $2.96M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $1.56M 10-Q · filed 2020-08-05 | $3.25M 10-Q · filed 2020-08-05 | $1.71M derived: sum of 3 quarters · filed 2021-02-24 | $5.14M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $1.69M 10-Q · filed 2020-05-06 | $150.00K derived: sum of 2 quarters · filed 2021-02-24 | $3.58M derived: sum of 3 quarters · filed 2021-02-24 | $3.77M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.90M derived: sum of 2 quarters · filed 2021-02-24 | $2.08M derived: sum of 3 quarters · filed 2021-02-24 | $1.80M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $3.43M 10-Q · filed 2019-11-12 | $3.62M derived: sum of 2 quarters · filed 2019-11-12 | $3.34M 10-Q · filed 2019-11-12 | $2.74M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $183.00K 10-Q · filed 2019-08-05 | -$92.00K 10-Q · filed 2019-08-05 | -$692.00K derived: sum of 3 quarters · filed 2019-08-05 | -$1.24M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | -$275.00K 10-Q · filed 2019-05-09 | -$875.00K derived: sum of 2 quarters · filed 2019-05-09 | -$1.43M derived: sum of 3 quarters · filed 2019-05-09 | -$2.17M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$600.00K 10-K · filed 2018-02-27 | -$1.15M derived: sum of 2 quarters · filed 2018-11-07 | -$1.90M derived: sum of 3 quarters · filed 2018-11-07 | -$38.00K 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$552.00K 10-Q · filed 2018-11-07 | -$1.30M derived: sum of 2 quarters · filed 2018-11-07 | -$2.33M 10-Q · filed 2018-11-07 | -$3.49M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | -$744.00K 10-Q · filed 2018-08-08 | -$1.77M 10-Q · filed 2018-08-08 | -$2.93M derived: sum of 3 quarters · filed 2018-08-08 | -$3.71M derived: sum of 4 quarters · filed 2018-08-08 | ||
| 2017-03-31 | -$1.03M 10-Q · filed 2018-05-10 | -$2.19M derived: sum of 2 quarters · filed 2018-05-10 | -$2.96M derived: sum of 3 quarters · filed 2018-05-10 | -$3.13M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$1.16M 10-K · filed 2018-02-27 | -$9.00K 10-K · filed 2017-02-23 | -$1.94M derived: sum of 2 quarters · filed 2018-02-27 | -$2.10M derived: sum of 3 quarters · filed 2018-02-27 | -$9.00K 10-K · filed 2019-02-22 | $436.00K 10-K · filed 2017-02-23 |
| 2016-09-30 | -$775.00K 10-K · filed 2018-02-27 | -$935.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.07M 10-Q · filed 2016-11-08 | -$466.00K derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | -$160.00K 10-K · filed 2018-02-27 | -$293.00K derived: sum of 2 quarters · filed 2018-02-27 | $309.00K derived: sum of 3 quarters · filed 2018-02-27 | $128.00K derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | -$133.00K 10-K · filed 2018-02-27 | $469.00K derived: sum of 2 quarters · filed 2018-02-27 | $288.00K derived: sum of 3 quarters · filed 2018-02-27 | $406.00K derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $602.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $421.00K derived: sum of 2 quarters · filed 2018-02-27 | $539.00K derived: sum of 3 quarters · filed 2018-02-27 | $118.00K 10-K · filed 2018-02-27 | $292.00K 10-K · filed 2016-02-19 | |
| 2015-09-30 | -$181.00K 10-Q · filed 2016-11-08 | -$63.00K derived: sum of 2 quarters · filed 2017-02-23 | -$484.00K 10-Q · filed 2016-11-08 | |||
| 2015-06-30 | $118.00K 10-K · filed 2017-02-23 | -$93.00K 10-Q · filed 2015-08-07 | -$303.00K 10-Q · filed 2015-08-07 | |||
| 2014-12-31 | -$905.00K 10-K · filed 2016-02-19 | -$922.00K derived: sum of 2 quarters · filed 2016-02-19 | -$1.14M derived: sum of 3 quarters · filed 2016-02-19 | -$919.00K 10-K · filed 2017-02-23 | ||
| 2014-09-30 | -$17.00K 10-K · filed 2016-02-19 | -$237.00K derived: sum of 2 quarters · filed 2016-02-19 | -$677.00K 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | -$220.00K 10-Q · filed 2015-08-07 | -$436.00K 10-Q · filed 2015-08-07 | ||||
| 2013-12-31 | $2.00K 10-K · filed 2016-02-19 | |||||
| 2012-12-31 | $6.00K 10-K · filed 2015-03-13 | |||||
| 2010-12-31 | $240.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |